CFO of Mednax, Inc. (MD) Vivian Lopez-blanco sells 3,700 shares of MD on 12/04/2012 at an average price of $80 a share.

Mednax, Inc. has a market cap of $3.94 billion; its shares were traded at around $79.79 with a P/E ratio of 16.8 and P/S ratio of 2.5. Mednax, Inc. had an annual average earning growth of 15% over the past 10 years. GuruFocus rated Mednax, Inc. the business predictability rank of 5-star.

This is the annual revenues and earnings per share of MD over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of MD.

CEO Recent Trades:

• CEO Roger Md Medel sold 50,000 shares of MD stock on 11/16/2012 at the average price of 73.65. Roger Md Medel owns at least 377,683 shares after this. The price of the stock has increased by 8.34% since.

CFO Recent Trades:

• CFO Vivian Lopez-blanco sold 3,700 shares of MD stock on 12/04/2012 at the average price of 80. Vivian Lopez-blanco owns at least 29,402 shares after this. The price of the stock has decreased by 0.26% since.

This is the insider trade history vs. stock price of MD. For the complete insider trading history of MD, click here.

Directors and Officers Recent Trades:

• Pres, American Anesthesiology Karl B Wagner sold 24,984 shares of MD stock on 11/29/2012 at the average price of 78.9. Karl B Wagner owns at least 82,744 shares after this. The price of the stock has increased by 1.13% since.
• COO, Pediatrix Division David A. Clark sold 2,019 shares of MD stock on 11/23/2012 at the average price of 77.16. David A. Clark owns at least 17,665 shares after this. The price of the stock has increased by 3.41% since.
• President, Pediatrix Division Michael D Stanley sold 1,470 shares of MD stock on 11/23/2012 at the average price of 77.16. Michael D Stanley owns at least 23,949 shares after this. The price of the stock has increased by 3.41% since.
• Director Michael Fernandez sold 12,931 shares of MD stock on 11/21/2012 at the average price of 76.5. Michael Fernandez owns at least 12,785 shares after this. The price of the stock has increased by 4.3% since.
• COO, Pediatrix Division David A. Clark sold 600 shares of MD stock on 11/20/2012 at the average price of 77.1. David A. Clark owns at least 17,665 shares after this. The price of the stock has increased by 3.49% since.

For the complete insider trading history of MD, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool